Daniel Richardson
@danielrich21
Followers
215
Following
315
Media
45
Statuses
393
Asst Prof at @UNC. Patient-Centered Care, Leukemia, Health Services, and Ethics Researcher @corp_UNC, @UNC_lineberger. Follower of Jesus. Tweets mine.
Chapel Hill
Joined November 2011
RT @UNC_Lineberger: This afternoon at #ASCO25, Daniel Richardson, MD, MSc, MA, will present at the rapid oral abstract session: Treatment p….
0
1
0
RT @UNC_Lineberger: @EthanBasch1 and @danielrich21 presented research findings on patient-reported outcomes and a decision support tool for….
0
6
0
RT @EnriqueSoto8: I'm incredibly honored to receive the @ASCO @ConquerCancerFd Advanced Clinical Research Award. With this funding, we will….
0
30
0
RT @csoncol: Bishal Gyawali @oncology_bg discusses the CSO RCT Checklist for design, analysis, and interpretation of cancer drug RCTs. http….
0
9
0
RT @mpdrc: Huge congratulations to @HKlepinMD , Associate Director of @AtriumHealthWFB Comprehensive Cancer Center, the #ASCO25 Geriatric O….
0
3
0
RT @WilliamDale_MD: Dr. Karen Mustian, introduced by Dr. Supriya Mohile, accepts her award from @ASCO for her work in #SupportiveCare. Ex….
0
4
0
RT @MazieTsangMD: Awesome slides on shared decision-making for older adults #gerionc! The session is also available on demand! Please check….
0
5
0
RT @cdumonti: Looking forward to sharing today w/ @danielrich21 @MelissaLoh21 @melisawongmd tools to facilitate shared decision-maki….
0
9
0
RT @WilliamDale_MD: I love this work, built on work by @danielrich21 , from one of his mentees. #GeriOnc #MedicalDecisionMaking #ASCOQLTY22.
0
1
0
RT @UNC_Lineberger: Using the wrong mathematical formula to assess heartbeat rhythms may lead oncologists to inappropriately stop life-savi….
0
2
0
RT @LeukDocJZ: Excited to present our newest paper in @JAMAOnc highlighting the discrepancy of QTc values and its effect in mgmt of onc pts….
0
14
0
RT @socmdm: Explore how considerations for preference research and integration into practice vary from bench to bedside and in-between with….
0
8
0
Thanks to co-authors .@LundJenny @ChrisJensenMD .Katie Reeder-Hayes, Chris Baggett, Xi (Josy) Zhou. And special thanks to UNC CIPHR for the New Investigator Award .@corp_UNC @UNC_CIPhER.
0
0
0
Perhaps you are wondering about AZA/VEN? .Our group addressed this question at ASH this year (manuscript forthcoming). Basically AZA = AZA/VEN for time at home.
1
0
3
Conclusions:.1. Time toxicity of tx is very high for both Intense and HMAs.2. Treatment choice may depend on pts' preference for time at home versus prolonging survival .3. We should track time at home on trials and develop interventions to improve time at home
1
0
2
Privileged to present #ASCO2022: Time at Home among older AML patients. Method: A propensity weighted SEER-Medicare dataset .Results:.1. Treatment burdens very high .2. Pts tx w/Intensive Induction lived longer, but had less time at home v. HMA-tx pts
5
16
75
RT @WilliamDale_MD: The Decison Making in #GeriOnc research group! . #ASCO22 .@MelissaLoh21 @danielrich21 .@EnriqueSoto8 .
0
7
0
RT @cdumonti: @MelissaLoh21 sharing her experience and research toward integrating cytogenetics, geriatric assessment, and patient values….
0
7
0
One of my best #ASH21 moments: Seeing Konan Beke (2nd year Med student at UNC) present our work. My hope will be that ASH serves as a launching pad for a long pt-centered career in hematology.
0
2
16